FDA accepts application for Roche’s Port Delivery System with ranibizumab (PDS) for treatment of neovascular or “wet” age-related macular degeneration (nAMD)
If approved, PDS would be the first and only eye implant with continuous drug delivery…
If approved, PDS would be the first and only eye implant with continuous drug delivery…
Pratteln, Switzerland, and Rockville, MD, USA, June 24, 2021 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen…
Acquires all royalty rights to Maxigesic® IV Assumes sole responsibility for HY-075 and HY-038 –…
– Data from Phase 3 study of Yselty® (linzagolix) for the treatment of uterine…
MONTEGO BAY, Jamaica, June 24, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness” or…
BOSTON, June 23, 2021 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology…
The PMDA enters 8th consecutive year of using Certara’s biosimulation software PRINCETON, N.J., June 23,…
MALVERN, Pa., June 23, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical…
Study highlights the clinical performance of NIS4® technology in diagnosing at-risk NASH in patients with…
FORT LAUDERDALE, Fla., June 23, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
HiFi Sequencing will be used on a cohort of rare disease cases with the aim…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., June 23, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
CAMBRIDGE, Mass., June 23, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical…
DEINOVE- Adoption of all the ordinary resolutions at the Shareholders’ Meeting of June 21, 2021…
For information Nicox’s NCX 470 Dolomites Phase 2 Results in Glaucoma Patients To Be Presented…
Saint–Herblain (France), June 23, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., June 23, 2021 (GLOBE NEWSWIRE) —…
TORONTO, June 23, 2021 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified…
06_23 PR Image Composite of Alternate Blister Pack Designs (25mg CBD & CBG Infused) NEW…
— Initiation of the ABILITY Study, a first-in-human trial, is expected in the third quarter…